Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

An International Pulmonary Embolism Registry Using EKOS

Completed

Conditions: Pulmonary Embolism and Thrombosis

Interventions: Device: EkoSonic Endovascular System with thrombolytic

First Posted Date: 2018-02-08

Last Posted Date: 2023-02-22

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1480

Registration Number: NCT03426124

Locations: 🇺🇸
Healthfinity, PLLC Advanced Cardiac & Vascular Clinic, Glendale, Arizona, United States
🇺🇸
Cedars - Sinai, Los Angeles, California, United States
🇺🇸
Radiology Imaging Associates, Englewood, Colorado, United States

and more 77 locations

Non-Complex Biliary Stones DSC vs ERC

Not Applicable

Completed

Conditions: Biliary Stones

Interventions: Device: DSC
Device: ERC

First Posted Date: 2018-02-05

Last Posted Date: 2025-01-17

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 250

Registration Number: NCT03421340

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
University of Colorado Hospital, Denver, Aurora, Colorado, United States
🇺🇸
Ochsner Clinic Foundation, New Orleans, Louisiana, United States

and more 5 locations

Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema

Not Applicable

Completed

Conditions: Emphysema

Interventions: Device: Endobronchial Coils

First Posted Date: 2017-12-04

Last Posted Date: 2023-08-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 120

Registration Number: NCT03360396

Locations: 🇦🇹
Ludwig Boltzmann Institut Fur COPD und pneumologische Epidemologie, Wien, Austria
🇫🇷
CHU Grenoble, Grenoble, France
🇫🇷
CHU Montpellier, Montpellier, France

and more 16 locations

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Device: SYNERGY 48 mm

First Posted Date: 2017-11-22

Last Posted Date: 2021-05-14

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT03350542

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
HealthEast St. Joseph's Hospital, Saint Paul, Minnesota, United States
🇺🇸
New York Presbyterian Hospital - Columbia University Medical Center, New York, New York, United States

and more 12 locations

A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC

Completed

Conditions: Hepatocellular Carcinoma

Interventions: Device: TheraSphere

First Posted Date: 2017-09-27

Last Posted Date: 2021-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 209

Registration Number: NCT03295006

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
University of Florida College of Medicine, Gainesville, Florida, United States
🇺🇸
Northwestern Memorial Hospital, Robert H Lurie Comprehensive Cancer Center, Chicago, Illinois, United States

and more 11 locations

Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies

Early Phase 1

Completed

Conditions: Carcinoma, Hepatocellular
Metastatic Colorectal Cancer

Interventions: Drug: BTG-002814

First Posted Date: 2017-09-25

Last Posted Date: 2021-07-19

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 8

Registration Number: NCT03291379

Locations: 🇬🇧
University College London Hospital, Bloomsbury, London, United Kingdom

PROMUS PREMIER™ China Post-Approval Study

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2017-09-06

Last Posted Date: 2025-07-01

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 2059

Registration Number: NCT03273023

Locations: 🇨🇳
The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

Chronic Obstructive Pulmonary Disease (COPD) Co-Pilot AIR Substudy of CLN0014

Terminated

Conditions: COPD Symptoms After Coil Procedure

First Posted Date: 2017-08-31

Last Posted Date: 2021-07-16

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 9

Registration Number: NCT03267992

Locations: 🇨🇭
Hôpitaux Universitaires de Genève (HUG) Service, Genève, Switzerland
🇨🇭
UniversitätsSpital, Zürich, Switzerland

Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)

Completed

Conditions: Venous Leg Ulcer

First Posted Date: 2017-08-22

Last Posted Date: 2021-12-14

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 76

Registration Number: NCT03257254

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸
University of California Davis Health, Sacramento, California, United States
🇺🇸
The Vascular Experts, Darien, Connecticut, United States

and more 11 locations

Strategic Management to Improve CRT Using Multi-Site Pacing Post Approval Study (Reference # C1918)

Not Applicable

Completed

Conditions: Left Ventricular Dysfunction

Interventions: Device: CRT-D

First Posted Date: 2017-08-22

Last Posted Date: 2022-01-03

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 586

Registration Number: NCT03257436

Locations: 🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸
Phoenix Cardiovascular Group, Phoenix, Arizona, United States
🇺🇸
Cardiology Associates of NEA, Jonesboro, Arkansas, United States

and more 51 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy